table of content
1 Study Coverage
1.1 DTaP and Tdap Vaccines Product Introduction
1.2 Global DTaP and Tdap Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global DTaP and Tdap Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global DTaP and Tdap Vaccines Sales in Volume for the Year 2017-2028
1.3 United States DTaP and Tdap Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States DTaP and Tdap Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States DTaP and Tdap Vaccines Sales in Volume for the Year 2017-2028
1.4 DTaP and Tdap Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States DTaP and Tdap Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of DTaP and Tdap Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 DTaP and Tdap Vaccines Market Dynamics
1.5.1 DTaP and Tdap Vaccines Industry Trends
1.5.2 DTaP and Tdap Vaccines Market Drivers
1.5.3 DTaP and Tdap Vaccines Market Challenges
1.5.4 DTaP and Tdap Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 DTaP and Tdap Vaccines Market Segment by Type
2.1.1 DTaP
2.1.2 Td
2.1.3 Tdap
2.2 Global DTaP and Tdap Vaccines Market Size by Type
2.2.1 Global DTaP and Tdap Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global DTaP and Tdap Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States DTaP and Tdap Vaccines Market Size by Type
2.3.1 United States DTaP and Tdap Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States DTaP and Tdap Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 DTaP and Tdap Vaccines Market Segment by Application
3.1.1 Adult
3.1.2 Pediatric
3.2 Global DTaP and Tdap Vaccines Market Size by Application
3.2.1 Global DTaP and Tdap Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global DTaP and Tdap Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global DTaP and Tdap Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States DTaP and Tdap Vaccines Market Size by Application
3.3.1 United States DTaP and Tdap Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States DTaP and Tdap Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States DTaP and Tdap Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global DTaP and Tdap Vaccines Competitor Landscape by Company
4.1 Global DTaP and Tdap Vaccines Market Size by Company
4.1.1 Top Global DTaP and Tdap Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global DTaP and Tdap Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global DTaP and Tdap Vaccines Price by Manufacturer (2017-2022)
4.2 Global DTaP and Tdap Vaccines Concentration Ratio (CR)
4.2.1 DTaP and Tdap Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of DTaP and Tdap Vaccines in 2021
4.2.3 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global DTaP and Tdap Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global DTaP and Tdap Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers DTaP and Tdap Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States DTaP and Tdap Vaccines Market Size by Company
4.5.1 Top DTaP and Tdap Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States DTaP and Tdap Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States DTaP and Tdap Vaccines Sales by Players (2020, 2021 & 2022)
5 Global DTaP and Tdap Vaccines Market Size by Region
5.1 Global DTaP and Tdap Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global DTaP and Tdap Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global DTaP and Tdap Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global DTaP and Tdap Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global DTaP and Tdap Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global DTaP and Tdap Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global DTaP and Tdap Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific DTaP and Tdap Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa DTaP and Tdap Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Corporation Information
7.1.2 Sanofi Pasteur Description and Business Overview
7.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
7.1.5 Sanofi Pasteur Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporation Information
7.2.2 GlaxoSmithKline Description and Business Overview
7.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
7.2.5 GlaxoSmithKline Recent Development
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Corporation Information
7.3.2 Protein Sciences Corporation Description and Business Overview
7.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
7.3.5 Protein Sciences Corporation Recent Development
7.4 Novartis AG
7.4.1 Novartis AG Corporation Information
7.4.2 Novartis AG Description and Business Overview
7.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
7.4.5 Novartis AG Recent Development
7.5 Seqirus
7.5.1 Seqirus Corporation Information
7.5.2 Seqirus Description and Business Overview
7.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
7.5.5 Seqirus Recent Development
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Corporation Information
7.6.2 Merck Sharp & Dohme Corp Description and Business Overview
7.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
7.6.5 Merck Sharp & Dohme Corp Recent Development
7.7 Astellas Pharma US, Inc
7.7.1 Astellas Pharma US, Inc Corporation Information
7.7.2 Astellas Pharma US, Inc Description and Business Overview
7.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
7.7.5 Astellas Pharma US, Inc Recent Development
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporation Information
7.8.2 Pfizer Inc Description and Business Overview
7.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
7.8.5 Pfizer Inc Recent Development
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporation Information
7.9.2 Johnson & Johnson Description and Business Overview
7.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
7.9.5 Johnson & Johnson Recent Development
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
7.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
7.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
7.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
7.11 AstraZeneca
7.11.1 AstraZeneca Corporation Information
7.11.2 AstraZeneca Description and Business Overview
7.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 AstraZeneca DTaP and Tdap Vaccines Products Offered
7.11.5 AstraZeneca Recent Development
7.12 Emergent BioSolutions Inc
7.12.1 Emergent BioSolutions Inc Corporation Information
7.12.2 Emergent BioSolutions Inc Description and Business Overview
7.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Emergent BioSolutions Inc Products Offered
7.12.5 Emergent BioSolutions Inc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 DTaP and Tdap Vaccines Industry Chain Analysis
8.2 DTaP and Tdap Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 DTaP and Tdap Vaccines Distributors
8.3 DTaP and Tdap Vaccines Production Mode & Process
8.4 DTaP and Tdap Vaccines Sales and Marketing
8.4.1 DTaP and Tdap Vaccines Sales Channels
8.4.2 DTaP and Tdap Vaccines Distributors
8.5 DTaP and Tdap Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
